Mandate

Vinge has advised Main Capital and Pointsharp in its strategic merger with SIVIS

August 10, 2023 M&A Corporate Tax

Pointsharp enables organizations to secure IT environments with a high level of control for IT departments combined with an intuitive mobile user experience.

Pointsharp has a broad solution offering in the identity and access management market related to multi-factor authentication, secure access, user provisioning and password management. SIVIS, founded in 1999 and having its base in Germany and Denmark, focuses on areas such as identity and access management and risk management.

The addition of SIVIS’ strong offering within identity and role management is expected to strengthen the combined group's position.

Vinge's team consisted of Filip Öhrner, Linus Adolfsson and Josef Groow.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026